Mrs. Alexandra Diane Janet Mancini - 21 Jan 2024 Form 4 Insider Report for InMed Pharmaceuticals Inc. (INM)

Role: Sr VP, Clinical Reg Affairs
Signature: /s/ Eric A Adams, attorney-in-fact for Mrs. Alexandra Diane Janet Mancini
Issuer symbol: INM
Transactions as of: 21 Jan 2024
Net transactions value: $0
Form type: 4
Filing time: 05 Mar 2024, 15:20:23 UTC
Previous filing: 26 Dec 2023
Next filing: 28 May 2024
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	INM	Employee Stock Option (Expiration)	Expiration (or cancellation) of long derivative position with value received	$0	-121	-0.23%	$0.000000	52,485	21 Jan 2024	Common shares	121	$312.73	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Converted from the Canadian dollar exercise price of C$420.75 using an exchange rate of C$1.3454 = $US1.00